[HTML][HTML] Therapeutic effects of green tea polyphenol (‒)-Epigallocatechin-3-Gallate (EGCG) in relation to molecular pathways controlling inflammation, oxidative stress …
D Mokra, M Joskova, J Mokry - International journal of molecular sciences, 2022 - mdpi.com
(‒)-Epigallocatechin-3-gallate (EGCG) is the most abundant polyphenol in green tea.
Thanks to multiple interactions with cell surface receptors, intracellular signaling pathways …
Thanks to multiple interactions with cell surface receptors, intracellular signaling pathways …
[HTML][HTML] Nutritional modulation of immune function: analysis of evidence, mechanisms, and clinical relevance
D Wu, ED Lewis, M Pae, SN Meydani - Frontiers in immunology, 2019 - frontiersin.org
It is well-established that the nutritional deficiency or inadequacy can impair immune
functions. Growing evidence suggests that for certain nutrients increased intake above …
functions. Growing evidence suggests that for certain nutrients increased intake above …
[HTML][HTML] Broad targeting of resistance to apoptosis in cancer
Apoptosis or programmed cell death is natural way of removing aged cells from the body.
Most of the anti-cancer therapies trigger apoptosis induction and related cell death networks …
Most of the anti-cancer therapies trigger apoptosis induction and related cell death networks …
Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications
BN Singh, S Shankar, RK Srivastava - Biochemical pharmacology, 2011 - Elsevier
An expanding body of preclinical evidence suggests EGCG, the major catechin found in
green tea (Camellia sinensis), has the potential to impact a variety of human diseases …
green tea (Camellia sinensis), has the potential to impact a variety of human diseases …
Recent advances in metal‐phenolic networks for cancer theranostics
Nanomedicine integrates different functional materials to realize the customization of
carriers, aiming at increasing the cancer therapeutic efficacy and reducing the off‐target …
carriers, aiming at increasing the cancer therapeutic efficacy and reducing the off‐target …
Bortezomib as the first proteasome inhibitor anticancer drug: current status and future perspectives
D Chen, M Frezza, S Schmitt, J Kanwar… - Current cancer drug …, 2011 - ingentaconnect.com
Targeting the ubiquitin-proteasome pathway has emerged as a rational approach in the
treatment of human cancer. Based on positive preclinical and clinical studies, bortezomib …
treatment of human cancer. Based on positive preclinical and clinical studies, bortezomib …
Plant‐inspired pyrogallol‐containing functional materials
Pyrogallol‐containing molecules are ubiquitous in the plant kingdom. The chemical
synthesis of these molecules remains challenging. Thus, they are obtained via purification …
synthesis of these molecules remains challenging. Thus, they are obtained via purification …
Impact of natural products on developing new anti-cancer agents
GM Cragg, PG Grothaus, DJ Newman - Chemical reviews, 2009 - ACS Publications
Throughout the ages, Nature has catered to the basic needs of humans, not the least of
which is the provision of medicines for the treatment of a wide spectrum of diseases. Plants …
which is the provision of medicines for the treatment of a wide spectrum of diseases. Plants …
[HTML][HTML] Proteasome inhibitors: an expanding army attacking a unique target
AF Kisselev, WA van der Linden, HS Overkleeft - Chemistry & biology, 2012 - cell.com
Proteasomes are large, multisubunit proteolytic complexes presenting multiple targets for
therapeutic intervention. The 26S proteasome consists of a 20S proteolytic core and one or …
therapeutic intervention. The 26S proteasome consists of a 20S proteolytic core and one or …
Cancer prevention by tea: animal studies, molecular mechanisms and human relevance
CS Yang, X Wang, G Lu, SC Picinich - Nature Reviews Cancer, 2009 - nature.com
Extracts of tea, especially green tea, and tea polyphenols have been shown to inhibit the
formation and development of tumours at different organ sites in animal models. There is …
formation and development of tumours at different organ sites in animal models. There is …